Design and proof of concept of a CRISPR/Cas13a-catalytic hairpin assembly framework for circulating microRNA detection in sepsis
Frontiers in Systems Biology · 20.11.2026 · 6
DOI: 10.3389/fsysb.2026.1968124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Systems Biology, online erschienen am 20.11.2026. Verfasst von Despina Panteleon und 12 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Sepsis remains a leading cause of mortality worldwide, largely because early diagnosis is slow. Current biomarkers such as C-reactive protein and procalcitonin lack specificity and need up to 24 h to peak, delaying diagnosis in a condition where each hour increases mortality risk. Circulating microRNAs are promising early biomarkers, reflecting rapid molecular changes in the host response to infection. We propose a diagnostic framework combining CRISPR/Cas13a molecular recognition with a Catalytic Hairpin Assembly amplification circuit. Cas13a is programmed to recognize a short microRNA; on activation it cleaves a synthetic substrate collaterally, releasing an initiator that triggers an enzyme-free amplification cascade. In a proof-of-concept experiment a complete redesigned hairpin set (H0, H1 and H2) raised the share of the hairpin pool migrating as the H1-H2 duplex from approximately 34% to approximately 90% relative to a published set used in the same architecture, measured as band intensity in parallel lanes of a single gel. This is reported as a preliminary observation: the comparison rests on technical replicates of one reaction and lacks the no-target control that would establish target-dependent operation of the complete cascade. The system is designed for integration into a portable microneedle-microfluidic biosensor that would permit minimally invasive, serial sampling with an end-to-end assay time of approximately 4 h per measurement; that device has not been built and is described here as a specification. The two microRNAs were chosen by exhaustive screening of a public whole-blood cohort. They separate septic patients from healthy volunteers well (ROC-AUC 0.95) but separate them from patients with non-infectious inflammation poorly (ROC-AUC 0.64), and no panel of up to 263 curated microRNAs improved on that second figure, which is the comparison that matters clinically. That evidence comes from whole blood, a cell-associated compartment, whereas the proposed device would sample interstitial fluid, which is cell-free; performance in the intended sample therefore remains an open question. This article presents a hypothesis and a design, together with the computational and bench evidence that bears on them. No sensitivity, specificity or clinical performance is claimed, and the experiments that would test the proposal are set out explicitly.
Zitieren
APA
Panteleon, D., Kerpinioti, M., Pierrakea, I., Pavli, M. E., Giannopoulos, S., Zormpa-Sfaellou, N., Anastasopoulos, K., Katsaros, A., Tzortzakis, G., Xydi, M., Karamperis, K., Patrinos, G. P., & Lagoumintzis, G. (2026). Design and proof of concept of a CRISPR/Cas13a-catalytic hairpin assembly framework for circulating microRNA detection in sepsis. Frontiers in Systems Biology, 6. https://doi.org/10.3389/fsysb.2026.1968124
Vancouver
Panteleon D, Kerpinioti M, Pierrakea I, Pavli ME, Giannopoulos S, Zormpa-Sfaellou N, et al. Design and proof of concept of a CRISPR/Cas13a-catalytic hairpin assembly framework for circulating microRNA detection in sepsis. Frontiers in Systems Biology. 2026;6. doi:10.3389/fsysb.2026.1968124
BibTeX
@article{Panteleon2026,
author = {Panteleon, Despina and Kerpinioti, Maria-Nikolina and Pierrakea, Irene and Pavli, Maria Electra and Giannopoulos, Spiros and Zormpa-Sfaellou, Nefeli and Anastasopoulos, Konstantinos and Katsaros, Andreas and Tzortzakis, Grigoris and Xydi, Myrto and Karamperis, Kariofyllis and Patrinos, George P. and Lagoumintzis, George},
title = {Design and proof of concept of a CRISPR/Cas13a-catalytic hairpin assembly framework for circulating microRNA detection in sepsis},
journal = {Frontiers in Systems Biology},
year = {2026},
volume = {6},
doi = {10.3389/fsysb.2026.1968124}
}
EUVIMED